Matches in SemOpenAlex for { <https://semopenalex.org/work/W2294620695> ?p ?o ?g. }
- W2294620695 endingPage "2134" @default.
- W2294620695 startingPage "2124" @default.
- W2294620695 abstract "Bombesin (BN) analogs bind with high affinity to gastrin-releasing peptide receptors (GRPRs) that are upregulated in prostate cancer and can be used for the visualization of prostate cancer. The aim of this study was to investigate the influence of radionuclide-chelator complexes on the biodistribution pattern of the 111In-labeled bombesin antagonist PEG2-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 (PEG2-RM26) and to identify an optimal construct for SPECT imaging. A series of RM26 analogs N-terminally conjugated with NOTA, NODAGA, DOTA and DOTAGA via a PEG2 spacer were radiolabeled with 111In and evaluated both in vitro and in vivo. The conjugates were successfully labeled with 111In with 100% purity and retained binding specificity to GRPR and high stability. The cellular processing of all compounds was characterized by slow internalization. The IC50 values were in the low nanomolar range, with lower IC50 values for positively charged natIn-NOTA-PEG2-RM26 (2.6±0.1 nM) and higher values for negatively charged natIn-DOTAGA-PEG2-RM26 (4.8±0.5 nM). The kinetic binding studies showed KD values in the picomolar range that followed the same pattern as the IC50 data. The biodistribution of all compounds was studied in BALB/c nu/nu mice bearing PC-3 prostate cancer xenografts. Tumor targeting and biodistribution studies displayed rapid clearance of radioactivity from the blood and normal organs via kidney excretion. All conjugates showed similar uptake in tumors at 4 h p.i. The radioactivity accumulation in GRPR-expressing organs was significantly lower for DOTA- and DOTAGA-containing constructs compared to those containing NOTA and NODAGA. 111In-NOTA-PEG2-RM26 with a positively charged complex showed the highest initial uptake and the slowest clearance of radioactivity from the liver. At 4 h p.i., DOTA- and DOTAGA-coupled analogs showed significantly higher tumor-to-organ ratios compared to NOTA- and NODAGA-containing variants. The NODAGA conjugate demonstrated the best retention of radioactivity in tumors, and, at 24 h p.i., had the highest contrast to blood, muscle and bones." @default.
- W2294620695 created "2016-06-24" @default.
- W2294620695 creator A5004010149 @default.
- W2294620695 creator A5008347976 @default.
- W2294620695 creator A5011722950 @default.
- W2294620695 creator A5011921150 @default.
- W2294620695 creator A5014071440 @default.
- W2294620695 creator A5026446163 @default.
- W2294620695 creator A5057419350 @default.
- W2294620695 creator A5074441028 @default.
- W2294620695 creator A5090698986 @default.
- W2294620695 date "2016-03-09" @default.
- W2294620695 modified "2023-10-15" @default.
- W2294620695 title "Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26" @default.
- W2294620695 cites W1503873650 @default.
- W2294620695 cites W1963992787 @default.
- W2294620695 cites W1975577875 @default.
- W2294620695 cites W1979041297 @default.
- W2294620695 cites W1991799972 @default.
- W2294620695 cites W1995823770 @default.
- W2294620695 cites W2002281967 @default.
- W2294620695 cites W2012966854 @default.
- W2294620695 cites W2031078156 @default.
- W2294620695 cites W2039831066 @default.
- W2294620695 cites W2049782036 @default.
- W2294620695 cites W2051983269 @default.
- W2294620695 cites W2057064048 @default.
- W2294620695 cites W2062099779 @default.
- W2294620695 cites W2062684742 @default.
- W2294620695 cites W2069824662 @default.
- W2294620695 cites W2076664198 @default.
- W2294620695 cites W2088027248 @default.
- W2294620695 cites W2092496716 @default.
- W2294620695 cites W2105255209 @default.
- W2294620695 cites W2108244776 @default.
- W2294620695 cites W2111002001 @default.
- W2294620695 cites W2118756958 @default.
- W2294620695 cites W2140687262 @default.
- W2294620695 cites W2144240397 @default.
- W2294620695 cites W2144862049 @default.
- W2294620695 cites W2328494350 @default.
- W2294620695 cites W2419608532 @default.
- W2294620695 cites W4211222029 @default.
- W2294620695 doi "https://doi.org/10.3892/ijo.2016.3429" @default.
- W2294620695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26983776" @default.
- W2294620695 hasPublicationYear "2016" @default.
- W2294620695 type Work @default.
- W2294620695 sameAs 2294620695 @default.
- W2294620695 citedByCount "25" @default.
- W2294620695 countsByYear W22946206952017 @default.
- W2294620695 countsByYear W22946206952018 @default.
- W2294620695 countsByYear W22946206952019 @default.
- W2294620695 countsByYear W22946206952020 @default.
- W2294620695 countsByYear W22946206952021 @default.
- W2294620695 countsByYear W22946206952022 @default.
- W2294620695 countsByYear W22946206952023 @default.
- W2294620695 crossrefType "journal-article" @default.
- W2294620695 hasAuthorship W2294620695A5004010149 @default.
- W2294620695 hasAuthorship W2294620695A5008347976 @default.
- W2294620695 hasAuthorship W2294620695A5011722950 @default.
- W2294620695 hasAuthorship W2294620695A5011921150 @default.
- W2294620695 hasAuthorship W2294620695A5014071440 @default.
- W2294620695 hasAuthorship W2294620695A5026446163 @default.
- W2294620695 hasAuthorship W2294620695A5057419350 @default.
- W2294620695 hasAuthorship W2294620695A5074441028 @default.
- W2294620695 hasAuthorship W2294620695A5090698986 @default.
- W2294620695 hasBestOaLocation W22946206951 @default.
- W2294620695 hasConcept C118303440 @default.
- W2294620695 hasConcept C134306372 @default.
- W2294620695 hasConcept C136339569 @default.
- W2294620695 hasConcept C139770010 @default.
- W2294620695 hasConcept C150903083 @default.
- W2294620695 hasConcept C170493617 @default.
- W2294620695 hasConcept C178790620 @default.
- W2294620695 hasConcept C185592680 @default.
- W2294620695 hasConcept C197336794 @default.
- W2294620695 hasConcept C197404232 @default.
- W2294620695 hasConcept C202751555 @default.
- W2294620695 hasConcept C207001950 @default.
- W2294620695 hasConcept C2777752497 @default.
- W2294620695 hasConcept C2777807558 @default.
- W2294620695 hasConcept C2778172261 @default.
- W2294620695 hasConcept C2778448772 @default.
- W2294620695 hasConcept C2779931791 @default.
- W2294620695 hasConcept C2984398910 @default.
- W2294620695 hasConcept C2989005 @default.
- W2294620695 hasConcept C33923547 @default.
- W2294620695 hasConcept C55493867 @default.
- W2294620695 hasConcept C71924100 @default.
- W2294620695 hasConcept C86803240 @default.
- W2294620695 hasConceptScore W2294620695C118303440 @default.
- W2294620695 hasConceptScore W2294620695C134306372 @default.
- W2294620695 hasConceptScore W2294620695C136339569 @default.
- W2294620695 hasConceptScore W2294620695C139770010 @default.
- W2294620695 hasConceptScore W2294620695C150903083 @default.
- W2294620695 hasConceptScore W2294620695C170493617 @default.
- W2294620695 hasConceptScore W2294620695C178790620 @default.
- W2294620695 hasConceptScore W2294620695C185592680 @default.